Recurrent Thrombotic Events after Catastrophic Antiphopholipid Syndrome

DOI QR Code

Park, Hayne-Cho (Department of Internal Medicine, Seoul National University Hospital) ;
Yoon, Hyun-Bae (Department of Internal Medicine, Seoul National University Hospital) ;
Lee, Tae-Woo (Department of Internal Medicine, Seoul National University Hospital) ;
Jung, Ji-Yong (Department of Internal Medicine, Seoul National University Hospital) ;
Chin, Ho-Jun (Renal Research Institute, Seoul National University College of Medicine) ;
Kim, Yon-Su (Department of Internal Medicine, Seoul National University Hospital) ;
Kim, Suhng-Gwon (Department of Internal Medicine, Seoul National University Hospital)

Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003;12:530-534. https://doi.org/10.1191/0961203303lu394oa
Erkan D. Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Autoimmun Rev 2006;6:98-103. https://doi.org/10.1016/j.autrev.2006.06.013
Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-1027. https://doi.org/10.1002/art.10187
Bucciarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006;54:2568-2576. https://doi.org/10.1002/art.22018
Espinosa G, Bucciarelli S, Asherson RA, Cervera R. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. Semin Thromb Hemost 2008;34:290-294. https://doi.org/10.1055/s-0028-1082274